HANSOH PHARMACEUTICAL GROUP CO LTD revenue for the last year amounted to 11.12 B HKD, the most of which — 6.42 B HKD — came from its highest performing source at the moment, Anti-tumor, the year earlier bringing 6.61 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought HANSOH PHARMACEUTICAL GROUP CO LTD 10.91 B HKD, and the year before that — 11.97 B HKD.